Description

1,2,5,6,7,8-Hexahydro-7-(4-Methylphenyl)-2,5-Dioxo-3-Quinolinecarboxylic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs) and fine chemicals. It is primarily sought by research institutions and manufacturers in the pharmaceutical, agrochemical, and specialty chemical industries for developing new therapeutic agents and high-value chemical products.

Application

• Pharmaceutical Intermediate: A key precursor in the research and synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders or with anti-inflammatory properties.
• Agrochemical Research: Used in the development of new pesticides and herbicides, leveraging its complex quinoline core structure.
• Organic Synthesis Building Block: Serves as a versatile scaffold for constructing more complex heterocyclic compounds in academic and industrial R&D laboratories.
• Material Science Research: Investigated for potential applications in creating organic electronic materials or specialty polymers due to its conjugated system.
• Biochemical Research: May be utilized as a tool compound or inhibitor in enzymatic studies and biochemical pathway analysis.

Basic Information

Product Name	1,2,5,6,7,8-Hexahydro-7-(4-Methylphenyl)-2,5-Dioxo-3-Quinolinecarboxylic Acid
CAS No.	924834-92-4
Molecular Formula	C17H15NO4
Molecular Weight	297.31 g/mol
Synonyms	7-(4-Methylphenyl)-1,2,5,6,7,8-hexahydro-2,5-dioxo-3-quinolinecarboxylic acid; 3-Quinolinecarboxylic acid, 1,2,5,6,7,8-hexahydro-7-(4-methylphenyl)-2,5-dioxo-; 7-p-Tolyl-1,2,5,6,7,8-hexahydro-2,5-dioxoquinoline-3-carboxylic acid; Hexahydro-7-(4-methylphenyl)-2,5-dioxo-3-quinolinecarboxylic acid; CAS 924834-92-4
EINECS	Contact for details

Quality Control

Our 1,2,5,6,7,8-Hexahydro-7-(4-Methylphenyl)-2,5-Dioxo-3-Quinolinecarboxylic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials such as strong oxidizing agents, strong bases, and strong acids. For long-term storage, consider storing under an inert atmosphere to maintain stability.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.